Essentials of Neurology and Neuromuscular Disorders


DISORDERS OF THE NERVOUS SYSTEM are common in childhood, and their diverse manifestations and complications may lead to diagnostic and surgical interventions that require anesthesia. Children with these disorders are subject to the same acute illnesses, such as acute appendicitis, as other children. Many neurologic disorders exert profound effects on other body systems that function under complex autonomic control. For example, dysfunction of bulbar musculature may predispose to regurgitation and aspiration in the perioperative period because protective reflexes may be impaired. Medications taken for chronic conditions may interact with anesthetic agents, which may have an impact on an underlying disorder in specific ways. The mechanisms of these interactions are becoming better understood with advances in molecular genetics. Anesthesiologists must have an understanding of the patient's underlying neurologic or neuromuscular condition and its influence on anesthesia management to optimize perioperative outcomes.

General Considerations

The term neurologic disorder encompasses a wide variety of conditions that may have extremely mild or very serious effects ( Table 24.1 ). These disorders are likely to be associated with a degree of physical, cognitive, or combined disabilities. Many children with severe physical disabilities have normal intelligence and are competent to make decisions about treatment options. Those with mild cognitive impairment may wish to be consulted about treatment choices; adolescents in particular must be involved in decision making. This approach is especially important for managing individuals with chronic disorders who are accustomed to thinking about health issues and who often have strong and well-defined opinions about how they wish to be treated.

TABLE 24.1
Neurologic Disorders
Condition Prevalence
Cerebral palsy: all types 2.2 per 1000 live births
Epilepsy 5–10 per 1000 all ages
Central nervous system tumors 1–5 per 1000 all ages
Neuromuscular disorders (all ages) 1 per 2900 total population
Congenital myopathy 1 per 28,600
Duchenne muscular dystrophy 1 per 3500
Myotonic dystrophy 1 per 12,000
Limb girdle dystrophy 1 per 90,000
Spinal muscular atrophy 1 per 74,000
Mitochondrial disorders 11.5 per 100,000 all ages

When planning anesthesia for these individuals, physicians must become knowledgeable about them and their conditions. Assumptions should not be made about their level of comprehension or about how they and their parents' view the choices available. It was formerly acceptable practice for children with chronic neurologic disorders to be excluded from the full range of therapeutic options, but it is now essential that all options are included.

Parents of children with chronic disorders of all types are usually accustomed to dealing with health care situations and often have thought carefully about the implications of various treatments. They know the child best and are usually most qualified to make decisions by proxy. Widespread use of the Internet has assisted many parents in becoming knowledgeable about their child's condition and about potential interventions. Their aims are usually entirely appropriate, and this knowledge may assist physicians in their collaboration with children and parents in determining optimal management. Occasionally, the information has been obtained from an unreliable source and may be inaccurate or inappropriate for a particular child. Misinformation can precipitate difficult situations for professionals, especially when there is a perceived disparity between the desires of the parents and those of the child and what the clinician considers to be in the child's best interest. The surgical team members usually are most involved in the process of obtaining informed consent, but the anesthesiologist must participate in the dialogue because anesthesia may be the part of treatment that carries the greatest risk.

Children with neurologic disorders usually have a regular physician overseeing their care, and this person should participate in the decision-making process. For elective procedures, the surgeon should establish contact with the child's regular pediatric specialist and anesthesiologist as soon as surgery is contemplated, inform them about the proposed operation, and seek their opinions to optimize perioperative management. Cognitive, communication, and behavioral problems; coexisting diseases; and drug therapy that may influence management of the anesthesia for these patients should be evaluated at an early stage. Some children may be receiving long-term respiratory support, including cough assist devices and home ventilation; all current therapies should be considered.

Oral communication may be difficult for some children with neurologic disorders. Use of age-appropriate assisted communication devices may help to ensure open communication between physician and patient. Parents' opinions and attempts to protect their children should be respected and understood as a consequence of previous experiences, stress, frustration, anger, and probably guilt. Each procedure has to be assessed in terms of morbidity, mortality, and probability of improving quality of life. All aspects must be clearly and objectively discussed with parents or guardians and informed consent forms signed.

Clinicians who are responsible for providing emergency care to children must have the knowledge and skills required to manage children with neurologic disorders. A preoperative assessment may be required on an urgent basis; a parent-held record of previous diagnoses and treatment is extremely helpful. Concurrent medications, previous reactions, and a history of complications such as respiratory insufficiency, electrolyte disturbance, or cardiac, renal, or hepatic dysfunction should be elicited before induction of anesthesia. A specific management plan for seizure medications is important for children who are likely to develop ileus postoperatively and thereby require a change from oral to intravenous (IV) medications.

Static Neurologic Disorders

Cerebral Palsies

Cerebral palsies are a group of disorders of movement, muscle, or posture that are caused by injury or abnormal development of the immature brain attributed to nonprogressive causes. The prevalence of cerebral palsy is 1 case per 500 live births. About 40% of these children are born premature. Eighty percent of cases are acquired prenatally and have no obvious cause, although they are associated with prematurity, low birth weight, placental insufficiency, maternal infection and pyrexia, intrauterine infections, intrauterine growth retardation, intracranial hemorrhage, and trauma. Birth complications, including asphyxia, are estimated to account for another 6% of cases. Postnatal causes of cerebral palsy (10%) usually arise from infectious causes (e.g., bacterial meningitis, viral encephalitis), trauma (e.g., motor vehicle collisions, falls, child abuse), or metabolic disturbance (e.g., hyperbilirubinemia).

Classification depends on the severity, distribution, and the nature of the motor deficit. With the advent of modern imaging techniques, including magnetic resonance imaging (MRI), understanding the pathogenesis of cerebral palsies has advanced dramatically. Clinical features are classified most commonly according to the type of motor deficit, its distribution, and the severity of the deficit ( Table 24.2 ). Involvement of a single limb is referred to as monoparesis , of both limbs on one side of the body as hemiparesis , of both lower limbs as paraparesis or diparesis , of three limbs as triparesis , and of all four limbs as tetraparesis or quadriparesis . The motor deficit may manifest as hypotonia, spasticity, or extrapyramidal features such as choreoathetoid/dystonic movements, dyskinesia, or ataxia. A descriptive classification includes neurologic deficit, severity, and distribution (e.g., spastic paraparesis or paraplegia dystonic hemiparesis). Paresis or palsies are terms used to denote differing severities.

TABLE 24.2
Cerebral Palsy
Type and Cause Motor Deficits Distribution Complications
Hypotonic Low axial tone Diffuse Learning disability
  • Syndromic

Variable limb tone
  • Dysgenesis

Deep tendon reflexes usually increased Epilepsy
  • Hypoxia-ischemia

Feeding dysfunction
Hearing or vision impairment
Respiratory infections
Spastic (pyramidal) Increased tone: pyramidal type Monoplegia
  • Hypoxia-ischemia

  • Vascular

Increased deep tendon reflexes Diplegia Epilepsy
Hemiplegia Contractures
Triplegia Feeding difficulties
Quadriplegia Learning difficulties
Dyskinetic (extrapyrimidal)

  • Hypoxia-ischemia

  • Neonatal hyperbilirubinemia

  • Metabolic

Involuntary movement: often a mixture of choreoathetosis, dystonia and dyskinesia May be diffuse involving all four limbs or confined to one or more limbs
Often coexists with spasticity
Hearing impairment
Contractures
Intellect can be maintained
Ataxic Usually generalized truncal and limb ataxia May be diffuse but often associated with diparesis Poor balance, speech difficulties, poor fine motor skills

  • Cerebral dysgenesis

  • Rare syndromes

May coexist with spasticity
Mixed Can be a combination of all above Often diffuse Mixture of all above

Children with cerebral palsies require neuroimaging to confirm the diagnosis and underlying cause of the condition. Although some centers use oral sedation (i.e., midazolam or chloral hydrate) for neuroimaging, many children require general anesthesia. They may require multiple anesthetics throughout their lifetimes because of the associated comorbidities (i.e., respiratory, gastrointestinal, neuromuscular, and orthopedic), common surgical conditions, and problems unique to cerebral palsies that require treatment.

Many of the comorbid conditions can affect anesthesia management. Understanding the pathophysiology and comorbidities of cerebral palsies allows anesthesiologists to anticipate and prevent perioperative complications.

Multisystem Comorbidities

Most children with cerebral palsies have clinically significant oromotor dysfunction, and when associated with gastroesophageal reflux, it may lead to recurrent aspiration, decreased respiratory reserve, esophageal stenosis, and malnutrition. Frequently used procedures include fundoplication, gastrostomy, and esophageal dilatation. Immobility, underhydration, and poor diet predispose patients to bowel stasis and constipation and, if severe, may result in fecal impaction. Malnutrition may depress immune responses, and electrolyte imbalance and anemia are common. Preoperative assessment of these parameters is essential.

Pulmonary complications are common causes of death in cerebral palsies. Aspiration associated with gastroesophageal reflux is the leading cause, and it may be exacerbated by excessive oral secretions, bulbar dysfunction, recurrent respiratory infection, and chronic lung disease. Scoliosis may also restrict pulmonary function, with cardiopulmonary involvement depending on the curve pattern and the severity of the curve (see Chapter 32 ).

Orthopedic operations are the most frequently performed procedures in children with moderate to severe cerebral palsies. Procedures include tendon releases to ease contractures, femoral osteotomy, and hip adductor and iliopsoas releases. The trend in orthopedic surgery is to perform multiple procedures involving tenotomies or osteotomies at different levels of all extremities during a single general anesthesic, rather than staging them during multiple operations. Scoliosis often requires surgery to prevent further deterioration in lung function and to stabilize the spine to facilitate ambulation and sitting. Spinal fusion is considered in all children with progressive curves greater than 40 to 50 degrees.

Botulinum toxin is commonly used to reduce muscle spasticity in affected children, and it may be injected with or without sedation or, more commonly, in children under general anesthesia. The need for repeated treatments (every 3-6 months) and the use of a nerve stimulator to confirm correct placement of the needle should be taken into consideration when assessing the child's need for sedation or anesthesia.

Approximately 30% of children with cerebral palsies have epilepsy. It is more common in spastic hemiplegia and quadriplegia, especially with a history of neonatal encephalopathy (53% vs. 29%) and less common in the ataxic and choreoathetotic forms. Secondary generalized and focal seizures frequently occur. Anticonvulsants should be maintained until the surgery date (given the morning of surgery) and restarted as soon as possible in the postoperative period.

Anesthesia Considerations for Cerebral Palsies

The many multisystem comorbidities and therapies specific to children with cerebral palsies must be understood to minimize perioperative complications. Risk factors include an inability to walk, severe neurologic deficit, major cognitive dysfunction, severe scoliosis, malnutrition, and the presence of a gastrostomy or tracheostomy. Severely compromised children can be optimally managed postoperatively with admission to the pediatric intensive care unit to provide analgesia with comprehensive monitoring, maximum support, and aggressive respiratory care; after their conditions are stabilized, they can be transferred to a setting with less intense monitoring.

All medications that the child is receiving should be reviewed; they may include anticonvulsant, antireflux, and antispasticity agents. Baclofen should not be discontinued abruptly because it can produce acute withdrawal symptoms. Oral dantrolene has also been used to reduce spasticity. Baclofen and dantrolene cause weakness; therefore the dose of neuromuscular blocking drugs may need to be reduced as these antispasticity drugs can delay the return of adequate respiratory effort during emergence from anesthesia.

Most of these children have above-average intelligence. They have the same emotional and cognitive concerns as others about undergoing anesthesia, including preoperative anxiety that may require premedication. Children with contractures, especially in the upper extremities, may present a challenge for establishing IV access. If gastroesophageal reflux is not controlled, consideration should be given to rapid-sequence induction. Although these children have a peripheral motor disorder, IV succinylcholine yields only a normal release of potassium, despite evidence of proliferation of extrajunctional acetylcholine receptors. Maintenance of and emergence from anesthesia requires special considerations, including the possibility of a reduced minimal alveolar concentration (MAC), resistance to neuromuscular blocking agents, and reduced bispectral index (BIS) measurements. If vomiting is likely to occur, the airway must be protected.

These children have normal responses to pain, which should be managed as if they were unaffected by cerebral palsy. Caudal or epidural analgesia may be a reasonable approach for perioperative pain management if the child does not have a ventriculoperitoneal shunt. Management and assessment of perioperative pain in children with neurocognitive impairment is addressed in Chapter 44 .

Malformations of the Nervous System

Malformations are common in pediatric neurologic practice and a frequent cause of early mortality. The appearance of the neural plate shows that the central nervous system (CNS) develops very rapidly in the 2-week embryo and continues until several years after birth. The cause of CNS malformations is largely uncertain, but timing appears to be more important than the nature of the insult in producing the specific type of malformation. Causative agents include maternal drugs such as sodium valproate, which is associated with neural tube defects (NTDs); infections such as cytomegalovirus, which can cause various cerebral lesions, depending on the time in gestation of the infection; toxins such as alcohol; vitamin deficiency (e.g., folic acid), and genetic disorders. Historically, because diagnostic investigation was limited, postmortem examination was required to demonstrate the neuropathologic changes causing the clinical disorder. MRI now can provide adequate images to enable a diagnosis in many instances (e.g., cortical dysplasia).

Neural Tube Defects: Cranial and Spinal Dysraphism

The fetal incidence of NTDs is 17 per 10,000 pregnancies; the live birth incidence is 5.7 to 6.7 per 10,000. NTDs are a group of birth defects presumed to have a common origin in failure of the neural tube to develop properly during the embryonic stage. NTDs include anencephaly, encephaloceles, and spina bifida.

The cause of NTDs is multifactorial, with genetic and environmental factors the most important. Approximately 10% of NTDs are caused by chromosomal abnormalities such as trisomies (i.e., 18, 13, and 21), triploidy, and 22q11 microdeletion. Some of the environmental causes include folate deficiency, maternal antiepileptic drugs (valproate, phenytoin, carbamazepine, and polytherapy), retinoins, and maternal diabetes.

Preconceptual folic acid supplementation has reduced the prevalence of NTDs by 30% to 50%. Along with antenatal ultrasound examination, screening is done for increased maternal serum levels of α-fetoprotein, reduced human chorionic gonadotropin levels, and reduced unconjugated estriol levels; termination of pregnancy in cases with positive test results has further reduced the prevalence of NTDs.

Anencephaly is a lethal disorder resulting from the neural tube failing to close between the 23rd and 26th day following conception. This leads to disorganization of neural elements and the absence of skull formation. Some deep cerebral structures may remain intact, and the brainstem may develop normally. With the latter situation, normal respiration and cardiovascular functions may develop, enabling the infant to survive for hours or days after birth. Other structures in the head and brain, including the eyes, face, and pituitary gland, may not develop normally. An infant with anencephaly is usually blind, deaf, and unable to feel pain.

Encephalocele is a herniation of neural tissue and meninges out of the skull through deficient skin and bone (see Fig. 26.12A ). They may be associated with other cerebral malformations. Encephaloceles found anteriorly are associated with underlying brain, orbital structures, or pituitary gland anomaly. Posteriorly, encephaloceles are associated with cerebral or cerebellar tissue that herniates through a bony defect in the posterior cranium. Intranasal encephaloceles may be difficult to detect. These defects carry a poor prognosis for long-term survival. The only treatment is reparative surgery; occasionally shunts are placed for resulting hydrocephalus. Most infants die, and in survivors, severe neurodevelopmental disability is common. Most of these children have hydrocephalus.

Spina bifida refers to a group of conditions in which there is abnormal or incomplete formation of the midline structures over the back (see Fig. 26.12B ). Skin, bony, and neural elements may be involved singly or in combination. Congenital malformations of the spinal cord may exist in isolation or in association with brain anomalies. These defects may present at birth, as in the case of the more severe and open lesions (i.e., spina bifida) or be identified later in childhood if the skin overlying the spinal defect is intact (e.g., spina bifida occulta). Those who develop a Chiari malformation may present with cervical cord or bulbar deficits, placing them at risk for respiratory embarrassment (see Figs. 26.13 , and 26.14 ). Children with spinal cord lesions are at increased risk for sensory deficits, making meticulous skin care and positioning essential to prevent pressure sores and damage to neuropathic joints.

Spina bifida occulta occurs in the absence of herniation of neural tissue or coverings so that the overlying skin appears to be intact and normal. In many cases, a hairy patch or a dermal sinus (i.e., sacral dimple) may communicate with the meninges or attach to the spinal cord or a lipoma that causes a fatty swelling overlying the bony defect. The spinal cord may be tethered by internal connection to such structures, making it vulnerable to trauma at surgery and during growth, especially at puberty. The spinal cord may be abnormally formed, with cartilaginous or bony spurs that damage or divide the cord during growth as the neural tissue grows at a slower rate than the surrounding bone (i.e., diastematomyelia). These infants may not be candidates for a caudal block because the spinal cord may end at an unusually low position.

Spina bifida cystica, the most common type of spinal dysraphism, manifests as an obvious lesion on the back. The defect may be diagnosed antenatally or at birth. The abnormally developed spinal cord may be covered by a layer of meninges (i.e., meningocele) or remain uncovered (i.e., myelomeningocele). The spinal level of the lesion is the major determinant of morbidity. Myelomeningoceles need to be repaired within a few days of birth to prevent infection and further damage to the neural tissues. A cerebrospinal fluid (CSF) leak or frank dural rupture may develop, leading to intravascular volume and electrolyte abnormalities that should be treated preoperatively.

When the defect is identified at birth, it is optimally managed in a specialist center by a multidisciplinary team (i.e., pediatrician, neurologist, neurosurgeon, orthopedic surgeon, and others) who can anticipate, prevent, and treat complications and assist in the child's long-term care. Children with dysraphism often develop postoperative hydrocephalus because of disrupted CSF flow and require a ventriculoperitoneal shunt. Long-term complications, including paraparesis, neurogenic bladder and bowel, renal insufficiency, trophic limb changes, pressure sores, joint contractures, and scoliosis may require surgical repair and future intervention. Children with NTDs may acquire latex allergy if they are exposed repeatedly to latex products (they do not have a genetic predisposition toward latex allergy). To prevent latex allergy, these children should be cared for in a latex-free environment. The anesthesia considerations for NTDs are presented in Chapter 26 .

Chiari Malformation

Chiari malformations of the nervous system may coexist with other anomalies and manifest in the neonatal period or later in the early decades of life ( Table 24.3 ).

TABLE 24.3
Chiari Malformations
Type Main Features Associated Abnormalities Neurologic Features
Chiari I Downward displacement of cerebellar tonsils >5 mm caudally through the foramen magnum Syringomyelia (in 20%-70%); hydrocephalus Later onset (>age 12 years), cervical cord signs: tetraparesis, sensory deficits of upper limbs
Chiari II Downward displacement of cerebellar tonsils, vermis fourth ventricle and brainstem with obstruction of CSF flow Supratentorial and infratentorial abnormalities; myelomeningocele or meningocoel in virtually all Present in neonate, macrocephaly, increased intracranial pressure, cranial nerve palsies, cord signs
Chiari III
(rare)
Downward displacement of cerebellum into posterior encephalocele; elongation of fourth ventricle Posterior defects: cervical spina bifida ± cranium bifidum Present in neonate with signs of hydrocephalus ± brainstem and cervical cord signs
Chiari IV
(extremely rare)
Cerebellar hypoplasia or primary cerebellar agenesis Usually none ± Ataxia

Chiari I. This is the mildest of the hindbrain malformations and is characterized by displacement of cerebellar tonsils more than 5 mm caudally through the foramen magnum. The brainstem and fourth ventricle retain a relatively normal position, although the fourth ventricle may be small and slightly distorted. Although the spectrum of Chiari I malformations is not usually associated with other cerebral abnormalities, syringomyelia is found in 20% to 70% of patients, depending on the degree and extent of disruption of normal CSF flow between the spine and cranium. Adequate surgical decompression at the foramen magnum and upper cervical spine is the treatment of choice for neuronal dysfunction, symptomatic syrinx, or hydrocephalus. Ventriculoperitoneal shunting may be required for hydrocephalus and syringostomy or syrinx shunting for cord drainage if the craniocervical decompression alone does not relieve the pressure in the syrinx.

Chiari II. This is a more extensive and complex abnormality than the Chiari I malformation, with infratentorial and supratentorial abnormalities. It affects 0.02% of births, females twice as often as males. The cerebellar tonsils, inferior vermis, fourth ventricle, and brainstem are herniated from a shallow posterior fossa through a wide foramen magnum with obstruction to CSF flow at the exit of the fourth ventricle. Occasionally the fourth ventricle becomes “trapped” or encysted and will enlarge to appear normal or dilated. There is virtually always a meningocele or meningomyelocele present, some with associated hydrocephalus.

Chiari III. This defect is very rare. There is herniation of the posterior fossa contents into an associated occipital or high cervical cephalocele with the other features of a Chiari II malformation. These patients have severe neurologic defects and a poor prognosis.

Chiari IV. This abnormality is controversial and extremely rare. Many authors consider the features of primary cerebellar agenesis as a Chiari IV malformation, but it must be differentiated from a Chiari II malformation associated with a “vanishing” cerebellum. In primary cerebellar agenesis, there are remnants of a residual cerebellum (for example, anterior quadrangular lobule), a normal brainstem, a normal-sized posterior fossa, and a normal spine. The lack of a meningomyelocele virtually excludes a Chiari II malformation.

Syringomyelia

Syringomyelia results from a glial cell–lined cavitation within the spinal cord. Diagnosis has been greatly simplified by the use of MRI, which provides images of the spinal cord and the tubular fluid-filled space within. Although the spectrum of Chiari I malformations is not usually associated with other cerebral abnormalities, syringomyelia is found in 20% to 70% of patients, depending on the degree and extent of disruption of normal CSF flow between the spine and cranium. Syringomyelia manifests with dissociated sensory loss, usually in the upper limbs, causing loss or impairment of pain and temperature sensation, which may cause trophic changes in the fingers and neuropathic joints. It may progress to paralysis and hyporeflexia later in life. The lower limbs may exhibit pyramidal signs; some lesions may extend upward (i.e., syringobulbia) and produce lower brainstem signs, such as stridor and laryngospasm (i.e., vocal cord palsy).

Treatment of syringomyelia is controversial, especially if the lesion is asymptomatic. Management may focus on associated disorders as syringomyelia may progress slowly or not at all.

Adequate surgical decompression at the foramen magnum and upper cervical spine is the treatment of choice for neuronal dysfunction, symptomatic syrinx, or hydrocephalus. Ventriculoperitoneal shunting may be required for hydrocephalus and syringostomy or syrinx shunting for cord drainage if the craniocervical decompression alone does not relieve the pressure in the syrinx.

Hydrocephalus

Hydrocephalus is defined as an increase in the volume of CSF in the brain, particularly the ventricles, associated with an increase in the intracranial pressure (ICP) with classical signs and symptoms. It results from overproduction or impaired drainage of CSF from the brain. In practice, overproduction is an uncommon source of hydrocephalus; these cases most often result from tumors of the choroid plexus. Obstructed drainage of CSF is the far more common source for hydrocephalus. The causes of hydrocephalus include intraventricular hemorrhage, Arnold-Chiari malformation, brain tumor, congenital obstruction, and myelomeningocele. Hydrocephalus may present with chronic or acute symptoms of ICP. Children typically present with a headache and irritability, but signs and symptoms can progress to lethargy, seizures, vomiting, and ophthalmoplegia as pressure within the brain increases. In infants, it presents as accelerated head growth, bulging fontanelle, poor feeding, sunsetting sign, and developmental delay. If left untreated, it may lead to a reduced level of consciousness, oculomotor palsies, sluggish pupillary light reactions, bradycardia, and eventually respiratory arrest. Diagnosis of hydrocephalus is confirmed by neuroimaging, often with computed tomography (CT) in the acute situation, followed by MRI.

Surgery is the definitive treatment for hydrocephalus. It usually involves inserting a drainage system to shunt CSF from the brain to another site in the body (see Fig. 26.11 ). After insertion of a shunt, children should be closely monitored for shunt complications; these include infection, blockage or fracture of the shunt, and overdrainage of CSF. The anesthesia considerations for treating hydrocephalus are discussed in Chapter 26 . An endoscopic cerebral aqueductoplasty or third venticulostomy may be helpful for obstructive hydrocephalus.

Disorders of Ventral Induction

Holoprosencephaly is a cephalic disorder in which the forebrain of the embryo fails to develop into discrete hemispheres with normal connections. There are three types:

  • 1.

    Lobar: There is almost complete separation of the hemispheres, and the corpus callosum is almost absent.

  • 2.

    Semilobar: The two hemispheres are divided posteriorly, with interhemispheric connections present anteriorly. The corpus callosum is absent anteriorly, and the thalami are fused in the midline.

  • 3.

    Alobar: An undivided and small forebrain with a dorsal sac may contain some cortex. Severe facial defects may include cyclopia (i.e., single orbit with fused globes), cebocephaly (i.e., single nostril), and a midline cleft lip.

Associated malformations (e.g., congenital heart disease, scalp deficits, polydactyly) are common. Chromosomal anomalies may be identified, and a complex syndromic disorder may occur in some of these children. The diagnosis rests on a careful description of the external and internal morphology using MRI, followed by genetic assessment. Complications include hydrocephalus, endocrine deficits, epilepsy, and severe complex disability, usually with a shortened life expectancy.

Disorders of Cortical Development

Malformations of the cerebral cortex are many and varied. Malformations of cortical development (MCD) are increasingly recognized as an important cause of epilepsy and developmental delay. It is estimated that up to 40% of children with refractory epilepsy have a cortical malformation. MCD encompass a wide spectrum of disorders with various underlying genetic etiologies and clinical manifestations. High-resolution imaging has dramatically improved our recognition of MCD. Disruptions at the various stages of development lead to characteristic MCDs. Disorders of neurogenesis give rise to microcephaly (small brain) or macrocephaly (large brain). Disorders of early neuroblast migration give rise to periventricular heterotopia (neurons located along the ventricles), whereas abnormalities later in migration lead to lissencephaly (smooth brain) or subcortical band heterotopia (smooth brain with a band of heterotopic neurons under the cortex). Abnormal neuronal migration arrest gives rise to overmigration of neurons in cobblestone lissencephaly. Lastly, disorders of neuronal organization cause polymicrogyria (abnormally small gyri and sulci). MRI has advanced the identification of these features and their classification.

Environmental agents and genetic abnormalities have been identified for many of these malformations, and genetic derangements can produce a multisystem syndrome. Some of the genes involved are the LIS1 gene, 4p− (Wolf-Hirschhorn), and 17p− (Miller-Dieker syndrome). Intrauterine insults in early pregnancy have been implicated in cases in which autopsy is performed. Clinical effects vary, and the severity depends on the site and extent of the lesion. Survivors may have no symptoms or have profound, complex neurodisability. Children may have learning disabilities, epilepsy, focal neurologic deficits, motor dysfunction, and other system involvement.

Progressive Neurologic Disorders

Primary Brain Tumors

The incidence of primary brain tumors is 2.6 per 100,000 children, and they account for 15% to 20% of all childhood malignancies. The male/female ratio is equal except for a male preponderance in medulloblastoma and germ cell tumors. One-third of these tumors occur before 5 years of age, and 75% occur before 10 years of age. CNS tumours are the second most common pediatric tumor, surpassed only by leukemia. Supratentorial tumors are common in the first 2 or 3 years of life, whereas infratentorial tumors predominate from ages 4 to 10 years. Two-thirds of the tumors are located infratentorially and one-third supratentorially ( Table 24.4 ). After the age of 10 years, tumors occur with equal frequency in both locations in the brain. Pathologic classification, which is based on the cell of origin and degree of malignancy, extends from grade I (benign) to grade IV (malignant).

TABLE 24.4
Common Central Nervous System Tumors in Childhood
Tumor Type Percentage of All Childhood CNS Tumors Clinical Features Treatment Prognosis or Survival
Medulloblastoma 14–20 Acute ataxia
↑ Intracranial pressure
Surgical excision + radiotherapy or chemotherapy in children <2 years 75% at 5 years
50% at 10 years
Cerebellar astrocytoma (80% cystic) 15–20 Subacute-chronic ataxia
Head tilt
± ↑ Intracranial pressure
Surgical excision 100% at 5 years, if totally excised
Posterior fossa ependymoma 6–10 Cranial nerve palsies
Stiff neck ataxia
↑ Intracranial pressure
Surgical excision
Radiotherapy
40% at 5 years but 14% if <5 years
Brainstem glioma 6–16 Cranial nerve palsies
Long tract signs
↑ Intracranial pressure late
(Stereotactic) biopsy if possible Radiotherapy ± chemotherapy, depends on age and cell type Survival variable and depends on cell type
Craniopharyngioma 6–10 Endocrine disorders
↑ Intracranial pressure
Visual impairment
Surgery
Hormonal therapy
Survival variable
Visual pathway glioma 3–5 Proptosis, ↓ vision
Associated disorders (e.g., neurofibromatosis type I)
Controversial and individualized Variable
Pineal region tumors <2 ↑ Intracranial pressure
Loss of upward gaze
Surgery ± radiotherapy Variable
Hemisphere glioma 25–30 α Location: ↑ intracranial pressure, seizures, focal neurologic deficit Surgery ± radiotherapy ± chemotherapy Depends on cell type
Meningioma <2 ↑ Intracranial pressure
Seizures
Surgery Variable
Ganglioma and dysembryoplastic neuroepithelial tumor (DNET) 1–5 Focal epilepsy Surgery Good
May cure epilepsy
Primitive neuroepithelial tumor (PNET) 1–2 ↑ Intracranial pressure, focal neurologic deficit Surgery + radiotherapy Poor
Intraventricular tumors, various cell types 5 ↑ Intracranial pressure: hydrocephalus Shunting and surgical excision Variable
Basal ganglia tumors, various cell types 5 Hemiparesis, dystonia Stereotactic biopsy
Radiotherapy if malignant
Depends on cell type
CNS, central nervous system; ±, with or without; ↓, decreased; ↑ increased.

The presentation depends on the age of the child and site of the tumor. Infants are typically irritable, with increasing head circumference, failure to thrive, and developmental regression. Older children develop headaches, nausea and vomiting, seizures, gait disturbances, and visual deficits. Supratentorial tumors can present with seizures, focal neurological deficit, personality change, visual field defects (optic pathway gliomas), and endocrine dysfunction (craniopharyngiomas). Infratentorial tumors present with cerebellar ataxia (medulloblastoma, cerebellar astrocytomas), nausea and vomiting, signs of increased ICP (ependymomas), and cranial nerve and pyramidal tract signs. If the lesion is rapidly expanding and is accompanied by significant cerebral edema or obstructs CSF drainage, ICP will increase. Occasionally, a hemorrhage occurs into the tumor, causing a dramatic increase in ICP with the associated signs and symptoms, necessitating emergency treatment. Ultimately, brainstem decompensation and death ensue if the lesion is left untreated.

Diagnosis of a primary brain tumor is usually confirmed with MRI and magnetic resonance spectroscopy (MRS). Tissue diagnosis by a biopsy is always desirable, although not always achievable. Microscopy of CSF may yield tumor cells and facilitate the diagnosis. Image-guided biopsy may be possible and is preferred for appropriately sited lesions.

Surgery is the mainstay of treatment and is usually combined with radiotherapy or chemotherapy, or both. Preoperatively, cerebral edema should be treated with corticosteroids to reduce ICP, alleviate symptoms and signs, and enable correction of fluid and electrolyte abnormalities. Seizures require anticonvulsant therapy. Nutrition may be poor and necessitate aggressive management with enteral and parenteral feedings. Operative intervention for increased ICP may require CSF diversion by shunting internally or externally. Depending on the tissue diagnosis and location, total resection of the tumor may be indicated, although the timing of the surgery may depend on whether the tumor should first be treated with radiation therapy or chemotherapy. Aggressive surgery with the intent of completely resecting the tumor improves the prognosis for many tumor types but carries with it significant risks of residual neurologic deficits.

The 5-year survival rate of greater than 60% for primary brain tumors largely reflects improved imaging, aggressive surgery, and evidence-based therapy. Unfortunately, children who survive CNS tumors frequently have permanent neurologic deficits, including epilepsy, learning disabilities, visual or hearing impairment, and growth and endocrine disorders. Short-term and long-term follow-up evaluations by specialist teams are required, along with careful emotional and social support for children and their families. Some children have genetic predispositions for CNS tumors, such as neurofibromatosis (i.e., schwannomas of the spinal cord, peripheral nerve tumors, skeletal deformities, carcinoid syndrome, and multiple endocrine neoplasia, including pheochromocytoma) and tuberous sclerosis (i.e., brain tumors, cardiac rhabdomyomas, renal abnormalities, tumors, and hepatoma) that require genetic analysis and long-term follow-up.

Tumors of the spinal cord are rare in childhood. They may be benign or malignant, sited within the cord (intramedullary) or outside (extramedullary), and are usually astrocytomas (60%) or ependymomas. Symptoms may initially be nonspecific and vague, especially in young children. These may include pain, paresthesia, paresis, sphincter disturbance, spinal deformity (astrocytomas), torticollis, and hydrocephalus (ependymoma). A diagnosis may be delayed owing to the vagueness of the symptoms, with an increased risk of spinal cord compression. Delayed decompression can cause vascular compromise, which may lead to total and irreversible paralysis of the limbs, bladder, and bowel, and permanent, severe disability. Diagnosis is best made by MRI of the cord, which provides details of the lesion and adjacent structures without the risk of further decompensation, a problem raised by the use of myelography in the past.

Treatment usually involves surgery to decompress the cord and excise or biopsy the lesion. For intramedullary tumors, excision may be impossible, and biopsy may risk further damage to the spinal cord. Cell type may be determined by CSF examination. Follow-up treatment with radiotherapy may be indicated. Children with established neurologic deficits require a program of rehabilitation.

Metabolic Disease

Inborn errors of carbohydrate, protein, or fat metabolism usually are genetic in origin. The molecular defects of many of these metabolic disorders have been identified. Most of these disorders are inherited as autosomal recessive.

Metabolic disorders may present differently depending on the age of the child. In the neonatal period, they present with poor feeding/suck, vomiting, hypotonia, respiratory compromise/apnea, progressive encephalopathy, and seizures, and the clinical picture may be mistaken for sepsis. It is therefore important to also consider metabolic disorders when thinking of infection as a potential cause of these symptoms in a neonate. In childhood, metabolic disorders can present with recurrent unexplained vomiting with dehydration, strokelike episodes, acute liver or renal failure, cardiomyopathy, unexplained encephalopathy, and seizures. These diseases may cause a static encephalopathy but more often produce a progressive course with loss of physical and intellectual skills. Some neurometabolic diseases are associated with intellectual deficits and some with physical deficits; systemic features may be prominent and neurologic signs are common ( Table 24.5 ).

TABLE 24.5
Neurometabolic Disorders
Lysosomal diseases
Mucolipidoses, sialidoses, disorders of glycoprotein metabolism
Peroxisomal disorders
Amino acid disorders
Organic acid disorders
Neurotransmitter disorders
Urea cycle disorders
Disorders of vitamin metabolism
Lactic acidosis
Respiratory chain disorders
Mitochondrial fatty acid β-oxidation defects
Disorders of cholesterol metabolism
Disorders of copper metabolism
Miscellaneous disorders

There are three main groups of neurometabolic diseases :

  • 1.

    Those with a known enzymatic defect, including disorders of amino acid metabolism (e.g., phenylketonuria), peroxisomal disorders (e.g., adrenoleukodystrophy), and lysosomal storage disorders (e.g., Tay-Sachs disease)

  • 2.

    Those with abnormal storage accumulation in CNS cells, including lysosomal storage disorders and mucopolysaccharidoses

  • 3.

    Those with no identified biochemical defect (e.g., Cockayne syndrome), a heterogeneous group that is shrinking as research identifies the biochemical and genetic defects.

There is considerable overlap among the three groups. All of these disorders are rare, and although some are treatable, most are relentlessly progressive and associated with early death. Many patients show a steady decline, with a gradual increase in symptoms and loss of function or a stepwise deterioration with bouts of acute illness leading to a sudden loss of function.

There are several basic laboratory tests that should be performed in every child with an acute illness in whom a metabolic disorder is a possibility. Blood glucose, ammonia, acid-base status, lactate, and urinary ketones are essential tests; other tests include plasma amino acids, urine organic acids, acylcarnitine profile, blood cell counts, liver function tests, coagulation studies, creatine kinase and uric acid. In an acute situation, the management consists of stopping feeds and starting an infusion of 10% glucose with appropriate electrolytes (150 mL/kg per day). Glucose supply at this infusion rate equates to normal hepatic glucose production. This is usually sufficient for disorders of reduced fasting tolerance, such as glycogen storage disorders or medium-chain acyl-CoA dehydrogenase deficiency (MCAD) (fatty acid oxidation disorders). Exogenous glucose may not be sufficient in disorders that are exacerbated by catabolism (organic acidurias or urea cycle disorders). However, exogenous glucose administration may be potentially dangerous in mitochondrial disorders (specifically pyruvate dehydrogenase deficiency) as a high glucose supply may enhance lactic acidosis. In most cases, the benefits of high glucose infusion outweigh the risks; however, lactate and acid-base status should be checked regularly.

Treatment is available for only a few of these diseases and consists primarily of dietary strategies, although some pharmacologic treatments are used. Started early, especially in the presymptomatic phase, treatment may prevent neurologic complications. An example is phenylketonuria, a disorder of amino acid metabolism. The prevalence varies by population, with an incidence of 1 case per 100,000 people in the United States. Screening occurs in the neonatal period, and affected children start a special diet. Those who have good dietary management throughout life may develop relatively few problems, although close monitoring by a specialist team of physicians and dieticians is essential to ensure metabolic stability. Unfortunately, treatments may be of questionable benefit for many children.

Disorders that cause lactic acidosis are the most common of these diseases, although many individuals who harbor the genetic substrate for one of these disorders may not express it or may come to diagnosis very late in life. The features of these diseases are extremely varied, and, although the neuropathologic, biochemical, and imaging abnormalities are well recognized, a precise diagnosis may remain elusive.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here